ABVD is a chemotherapy regimen used in the first-line treatment of Hodgkin lymphoma, supplanting the older MOPP protocol. It consists of concurrent treatment with the chemotherapy drugs:
Adriamycin (doxorubicin/hydroxydaunorubicin, the H in CHOP)
Bleomycin
Vinblastine
Dacarbazine (similar to procarbazine, the P in MOPP)

It is treatment for cancer consisting of 4 stages of treatment by drugs called a-adriamycin / b- bleomycin / v-vinblastyn and d- dacarbazine

Adriamycin is for intravenous (IV) use only and should only be given under the supervision of a doctor experienced in the use of cancer chemotherapy agents. If Adriamycin accidentally leaks into surrounding tissue, the skin and/or muscle may be severely damaged. Notify your doctor immediately if redness, pain, or swelling at or around the injection site occur.
Drinking extra fluids while you are using Adriamycin is recommended. Check with your doctor for instructions. If Adriamycin accidentally spills on your skin, wash it off immediately with soap and water.
Keep this product, as well as syringes and needles, out of the reach of children and away from pets. Do not reuse needles, syringes, or other materials. Dispose of properly after use.
Adriamycin may lower your body's ability to fight infection. Prevent infection by avoiding contact ...more

The combination chemotherapy regimen known as ABVD consists of the following drugs:

Adriamycin (doxorubicin)
Bleomycin
Vinblastine
Dacarbazine

Almost since it was first established in 1975, the ABVD regimen has been considered the 'gold standard' for the treatment of virtually all stages of Hodgkins lymphoma (especially early-stages) and it is currently regarded as such by highly influential guideline-setting groups including the National Comprehensive Cancer Network, the German Hodgkins Study Group, and the American Society of Clinical Oncology.

Source: google search

Some venereal disease.